PMID- 36594530
OWN - NLM
STAT- MEDLINE
DCOM- 20230330
LR  - 20230417
IS  - 1897-4279 (Electronic)
IS  - 0022-9032 (Linking)
VI  - 81
IP  - 3
DP  - 2023
TI  - Headache after transcatheter closure of atrial septal defect: An attempt to 
      explain its origin in the pediatric population.
PG  - 259-264
LID - 10.33963/KP.a2023.0001 [doi]
AB  - BACKGROUND: Transcatheter closure of atrial septal defect (ASD) has become the 
      treatment of choice for most patients. About 5% of them suffer from transient 
      headache episodes (THE) after the procedure, whose etiology is unclear. AIMS: To 
      evaluate risk factors for THE occurrence after transcatheter closure of ASD in 
      the pediatric population. METHODS: Eight hundred and forty patients, after 
      transcatheter ASD closure with nitinol devices, from a single center, were 
      included in retrospective analysis. THE was defined as occurring up to 24 hours 
      after the procedure. A logistic regression model including age, weight, ASD 
      diameter, device size, presence of nitinol coating on the device, fluoroscopy 
      time, application of balloon calibration, device oversizing, and residual shunt 
      after 24 hours was created to evaluate risk factors for THE occurrence. RESULTS: 
      There were 40 patients with THE (4.8%), 70% female and 30% male. The median age 
      was 13 (7.35-16) years. In patients with headache, balloon calibration (BC) was 
      performed more frequently (82.5% vs. 43.3%; P <0.001). The balloon waist median 
      (interquartile range [IQR]), 19 (16-22) mm vs. 15 mm (12-18) mm (P <0.001), and 
      device size median (IQR), 18 (13.5-22) mm vs. 14 (11-17) mm (P <0.001) were 
      larger, and residual shunt after 24 hours (12.5% vs. 4.9%; P = 0.03) and a year 
      (7.5 vs. 1.0%; P <0.001) were more frequent. ASD size and the prevalence of 
      double/multiple ASD were similar in both groups. Age, BC application, no nickel 
      release protection, duration of fluoroscopy, and device oversizing were 
      predictors of THE (P <0.001). CONCLUSIONS: BC during percutaneous ASD closure and 
      the lack of a protective layer against nickel release on the device are risk 
      factors for headache occurrence in the early postprocedural period.
FAU - Smerdzinski, Sebastian
AU  - Smerdzinski S
AD  - Department of Congenital Heart Defects and Pediatric Cardiology, Silesian Center 
      for Heart Diseases, Zabrze, Poland. smerdzinski@gmail.com.
AD  - Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, 
      Poland. smerdzinski@gmail.com.
FAU - Galeczka, Michal
AU  - Galeczka M
AD  - Department of Congenital Heart Defects and Pediatric Cardiology, Silesian Center 
      for Heart Diseases, Zabrze, Poland.
FAU - Tyc, Filip
AU  - Tyc F
AD  - Department of Congenital Heart Defects and Pediatric Cardiology, Silesian Center 
      for Heart Diseases, Zabrze, Poland.
AD  - Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, 
      Poland.
FAU - Knop, Mateusz
AU  - Knop M
AD  - Department of Congenital Heart Defects and Pediatric Cardiology, Silesian Center 
      for Heart Diseases, Zabrze, Poland.
AD  - Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, 
      Poland.
FAU - Bialkowski, Jacek
AU  - Bialkowski J
AD  - Department of Congenital Heart Defects and Pediatric Cardiology, Silesian Center 
      for Heart Diseases, Zabrze, Poland.
AD  - Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, 
      Poland.
FAU - Fiszer, Roland
AU  - Fiszer R
AD  - Department of Congenital Heart Defects and Pediatric Cardiology, Silesian Center 
      for Heart Diseases, Zabrze, Poland.
AD  - Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, 
      Poland.
LA  - eng
PT  - Journal Article
DEP - 20230103
PL  - Poland
TA  - Kardiol Pol
JT  - Kardiologia polska
JID - 0376352
RN  - 2EWL73IJ7F (nitinol)
SB  - IM
MH  - Humans
MH  - Child
MH  - Male
MH  - Female
MH  - Adolescent
MH  - Cardiac Catheterization/adverse effects/methods
MH  - Retrospective Studies
MH  - *Heart Septal Defects, Atrial/surgery/etiology
MH  - Headache/etiology
MH  - Treatment Outcome
MH  - Echocardiography, Transesophageal
MH  - *Septal Occluder Device/adverse effects
OTO - NOTNLM
OT  - balloon calibration
OT  - headache
EDAT- 2023/01/04 06:00
MHDA- 2023/03/30 06:11
CRDT- 2023/01/03 06:43
PHST- 2022/12/14 00:00 [received]
PHST- 2022/12/14 00:00 [accepted]
PHST- 2023/03/30 06:11 [medline]
PHST- 2023/01/04 06:00 [pubmed]
PHST- 2023/01/03 06:43 [entrez]
AID - VM/OJS/J/93219 [pii]
AID - 10.33963/KP.a2023.0001 [doi]
PST - ppublish
SO  - Kardiol Pol. 2023;81(3):259-264. doi: 10.33963/KP.a2023.0001. Epub 2023 Jan 3.